Document:

Standard Form of  Warrant

 EXHIBIT 10.2 
 FORM OF WARRANT 
 NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, OR OTHERWISE TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS (I) PURSUANT TO
REGISTRATION UNDER THE SECURITIES ACT OR (II) IN COMPLIANCE WITH AN EXEMPTION THEREFROM AND ACCOMPANIED, IF REQUESTED BY BIOJECT MEDICAL TECHNOLOGIES INC., WITH AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH TRANSFER IS IN
COMPLIANCE WITH AN EXEMPTION THEREFROM. 
  

			
	 Warrant No. _____
	  	Number of Shares: ______
		  	(subject to adjustment)
	 Date of Issuance: ________
	  	

 WARRANT 
 TO PURCHASE COMMON STOCK OF 
 BIOJECT MEDICAL TECHNOLOGIES INC. 
 EXPIRING ON _______ 
 THIS IS TO CERTIFY
THAT, for value received, _________, (the “Registered Holder”), or his permitted assigns, is entitled to purchase from BIOJECT MEDICAL TECHNOLOGIES INC., an Oregon corporation (the “Company”), at the place where the
Warrant Office designated pursuant to Section 2.1 is located, at a purchase price per share of $_______ (as adjusted pursuant to the terms of this Warrant, the “Exercise Price”), ________shares of duly authorized, validly
issued, fully paid and nonassessable shares of Common Stock, no par value per share (“Common Stock”), of the Company, and is entitled also to exercise the other appurtenant rights, powers and privileges hereinafter set forth. The
number of shares of the Common Stock purchasable hereunder and the Exercise Price are subject to adjustment in accordance with Article III hereof. This Warrant shall expire at 5:00 p.m., New York time, on _______. 
 Certain Terms used in this Warrant are defined in Article IV. 
 ARTICLE I 
 EXERCISE OF WARRANT 
 1.1 Method of Exercise. This Warrant may be exercised by the Registered Holder as a whole or in part from time to time until _______, at which
time this Warrant shall expire and be of no further force or effect; provided, however, that the minimum number of Warrant Shares that may be purchased on a single exercise shall be the entire number of shares remaining available for exercise
hereunder. To exercise this Warrant, the Registered Holder or permitted assignees of all rights of the Registered Holder shall deliver to the Company, at the Warrant Office designated in Section 2.1(a), a written notice in the form of the
Purchase Form attached as Exhibit A hereto, stating therein the election of the Registered Holder or such permitted assignees of the Registered Holder to exercise this Warrant in the manner provided in the Purchase Form, (b) payment in full of
the Exercise Price (in the manner described below) for all Warrant Shares purchased hereunder, and (c) this Warrant. Subject to compliance with Section 3.1(a)(vii), this Warrant shall be deemed to be exercised on the date of receipt by the
Company of the Purchase Form, accompanied by payment for the Warrant Shares to be purchased and surrender of this Warrant, as aforesaid, and such date is referred to herein as the “Exercise Date.” Upon such exercise (subject as aforesaid),
the Company shall issue and deliver to the Registered Holder a certificate for the full number of the Warrant Shares 

 
purchasable by the Registered Holder hereunder, against the receipt by the Company of the total Exercise Price payable hereunder for all such Warrant Shares,
in cash or by certified or cashier’s check. The Person in whose name the certificate(s) for Common Stock is to be issued shall be deemed to have become a holder of record of such Common Stock on the Exercise Date. 
 1.2 Fractional Shares. No fractional shares of Common Stock shall be issued upon exercise of this Warrant. Instead of any fractional shares of
Common Stock that would otherwise be issuable upon exercise of this Warrant, the Company shall pay a cash adjustment in respect of such fractional interest equal to the fair market value of such fractional interest as determined in good faith by the
Board of Directors. 
 1.3 Purchase of Warrants by the Company. The Company shall have the right, except as limited by law, other
agreement, or herein, to purchase or otherwise acquire Warrants at such time, in such manner, and for such consideration as it may deem appropriate. 
 1.4 Cancellation of Warrants. In the event the Company shall purchase or otherwise acquire the Warrants, the same shall thereupon be cancelled by it and retired. 
 ARTICLE II 
 WARRANT OFFICE;
TRANSFER 
 2.1 Warrant Office. The Company shall maintain an office for certain purposes specified herein (the “Warrant
Office”), which office shall initially be the Company’s office at 20245 S.W. 95th Avenue, Tualatin, Oregon 97062, and may subsequently be such other office of the Company or of any transfer agent of the Common Stock in the continental
United States of which written notice has previously been given to the Registered Holder. The Company shall maintain, at the Warrant Office, a register for the Warrant in which the Company shall record the name and address of the Registered Holder,
as well as the name and address of each permitted assignee of the rights of the Registered Holder. 
 2.2 Ownership of Warrant. The
Company may deem and treat the Registered Holder as the holder and owner hereof (notwithstanding any notations of ownership or writing hereon made by anyone other than the Company) for all purposes and shall not be affected by any notice to the
contrary, until presentation of this Warrant for registration of transfer as provided in this Article II. 
 2.3 Transfer of Warrants.
The Company agrees to maintain at the Warrant Office books for the registration and transfer of this Warrant. Subject to the restrictions on transfer of Warrants in Section 2.8, the Company, from time to time, shall register the transfer of
this Warrant in such books upon surrender of this Warrant at the Warrant Office, properly endorsed, together with a written assignment of this Warrant, substantially in the form of the Assignment attached as Exhibit B hereto. Upon any such
transfer, a new Warrant shall be issued to the transferee, and the Company shall cancel the surrendered Warrant. The Registered Holder shall pay all taxes and all other expenses and charges payable in connection with the transfer of Warrants
pursuant to this Section 2.3. 
 2.4 Acknowledgement of Rights. The Company will, at the time of exercise of this Warrant in
accordance with the terms hereof, upon request of the Registered Holder, acknowledge in writing its continuing obligation to afford to such holder any rights to which such holder shall continue to be entitled after such exercise in accordance with
the provisions of this Warrant, provided that if the holder of this Warrant shall fail to make any such request, such failure shall not affect the continuing obligation of the Company to afford to such holder any such rights. 
 2.5 No Rights as Shareholder Until Exercise. This Warrant does not entitle the Registered Holder to any voting rights or other rights as a
shareholder of the Company prior to the exercise hereof. Upon the surrender of this Warrant and the payment of the aggregate Exercise Price, the Warrant Shares so purchased shall be and be deemed to be issued to the Registered Holder as the record
owner of such shares as of the close of business on the Exercise Date. 
  

 2 

 2.6 Expenses of Delivery of Warrants. Except as provided in Section 2.3 above, the Company
shall pay all reasonable expenses, taxes (other than transfer taxes), and other charges payable in connection with the preparation, issuance and delivery of Warrants and related Warrant Shares hereunder. 
 2.7 Compliance with Securities Laws. The Registered Holder (and its transferees and assigns), by acceptance of this Warrant, covenants and agrees
that such Registered Holder is acquiring the Warrants evidenced hereby, and, upon exercise hereof, the Warrant Shares, for its own account as an investment and not with a view to distribution thereof. Neither this Warrant nor the Warrant Shares
issuable hereunder have been registered under the Securities Act or any state securities laws and no transfer of this Warrant or any Warrant Shares shall be permitted unless the Company has received notice of such transfer in the form of the
assignment attached hereto as Exhibit B, accompanied, if requested by the Company, by an opinion of counsel reasonably satisfactory to the Company that an exemption from registration of such Warrant or Warrant Shares under the Securities Act
is available for such transfer, except that no such opinion shall be required with respect to the Warrant Shares after the registration for resale of the Warrant Shares has become effective if the Warrant Shares are sold pursuant to the registration
statement. Upon any exercise of the Warrants prior to effective registration for resale or except as in accordance with Rule 144 under the Securities Act, certificates representing the Warrant Shares shall bear a restrictive legend substantially
identical to that set forth as follows: 
 “The securities represented by this certificate have not been registered under the Securities
Act of 1933, as amended, or the securities laws of any state (collectively, the “Acts”). Neither the shares nor any interest therein may be offered, sold, transferred, pledged, or otherwise disposed of in the absence of an effective
registration statement with respect to the shares under all of the applicable Acts, or an opinion of counsel satisfactory to Bioject Medical Technologies Inc. to the effect that such registrations are not required.” 
 (a) Any purported transfer of the Warrant or Warrant Shares not in compliance with the provisions of this section shall be null and void. Stop transfer
instructions have been or will be imposed with respect to the Warrant Shares so as to restrict resale or other transfer thereof, subject to this Section 2.7. 
 ARTICLE III 
 ANTI-DILUTION PROVISIONS 
 3.1 Adjustment of Exercise Price and Number of Warrant Shares. The Exercise Price shall be subject to adjustment from time to time as hereinafter
provided in this Article III. Upon each adjustment of the Exercise Price, except pursuant to Sections 3.1(a)(iii) and (iv), the Registered Holder shall thereafter be entitled to purchase, at the Exercise Price resulting from such adjustment, the
number of shares of the Common Stock obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares of the Common Stock purchasable pursuant hereto immediately prior to such adjustment and dividing
the product thereof by the Exercise Price resulting from such adjustment. 
 (a) Exercise Price Adjustments. The Exercise Price shall
be subject to adjustment from time to time as follows: 
 (i) Adjustment for Stock Splits and Combinations. If the Company shall, at
any time or from time to time after the date hereof (the “Original Issue Date”) while this Warrant remains outstanding, effect a subdivision of the outstanding Common Stock, the Exercise Price in effect immediately before such
subdivision shall be proportionately decreased. Conversely, if the Company shall at any time or from time to time after the Original Issue Date combine the outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in
effect immediately before such combination shall be proportionately increased. Any adjustment under this Section 3.1(a)(i) shall become effective at the close of business on the date the subdivision or combination becomes effective. 

(ii) Adjustment for Common Stock Dividends and Distributions. If the Company, at any time or from time to time after the Original Issue Date
while this Warrant remains outstanding makes, or fixes a 

  

 3 

 
record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in additional shares of Common
Stock, in each such event the Exercise Price that is then in effect shall be decreased as of the time of such issuance or, in the event such record date is fixed, as of the close of business on such record date, by multiplying the Exercise Price
then in effect by a fraction (i) the numerator of which is the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and (ii) the
denominator of which is the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of
such dividend or distribution; provided, however, that if such record date is fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed therefor, the Exercise Price shall be recomputed
accordingly as of the close of business on such record date, and thereafter the Exercise Price shall be adjusted pursuant to this Section 3.1(a)(ii) to reflect the actual payment of such dividend or distribution. 
 (iii) Adjustment for Reclassification, Exchange, and Substitution. If at any time or from time to time after the Original Issue Date while this
Warrant remains outstanding, the Common Stock is changed into the same or a different number of shares of any class or classes of stock, whether by recapitalization, reclassification, or otherwise (other than an Acquisition, Asset Transfer,
subdivision or combination of shares, stock dividend, reorganization, merger, consolidation, or sale of assets provided for elsewhere in this Section 3.1(a)), in any such event the Registered Holder shall have the right thereafter to convert
such stock into the kind and amount of stock and other securities and property receivable upon such recapitalization, reclassification or other change by holders of the maximum number of shares of Common Stock into which such shares of Common Stock
could have been converted immediately prior to such recapitalization, reclassification or change, all subject to further adjustment as provided herein or with respect to such other securities or property by the terms thereof. 
 (iv) Reorganizations, Mergers, Consolidations, or Sales of Assets. If at any time or from time to time after the Original Issue Date while this
Warrant remains outstanding, there is a capital reorganization of the Company, an Acquisition, an Asset Transfer (other than a recapitalization, or subdivision, combination, reclassification, exchange, or substitution of shares provided for
elsewhere in this Section 3.1(a)), as a part of such capital reorganization, Acquisition, or Asset Transfer, provision shall be made so that the Registered Holder shall thereafter be entitled to receive upon exercise hereof the number of shares
of stock or other securities or property to which a holder of the number of shares of Common Stock deliverable upon exercise immediately prior to such event would have been entitled as a result of such capital reorganization, subject to adjustment
in respect of such stock or securities by the terms thereof. In any such case, appropriate adjustment shall be made in the application of the provisions of this Section 3.1(a) with respect to the rights of the Registered Holder after the
capital reorganization, Acquisition, or Asset Transfer to the end that the provisions of this Section 3.1(a) (including adjustment of the Exercise Price then in effect and the number of shares issuable upon exercise) shall be applicable after
that event and be as nearly equivalent as practicable. 
 (v) Distributions of Securities. In case of any distribution of any
security (including rights or warrants to subscribe for any such securities) of the Company (except Common Stock), evidences of its indebtedness, cash, or other assets to all of the holders of its Common Stock, then in each such case the Exercise
Price in effect thereafter shall be determined by multiplying the Exercise Price in effect immediately prior thereto by a fraction, the numerator of which shall be the total number of outstanding shares of Common Stock multiplied by the Current
Market Price on the record date mentioned below, less the fair market value (as determined in good faith by the Board of Directors) of the securities, evidences of indebtedness, cash, or other assets distributed by the Company, and the denominator
of which shall be the total number of outstanding shares of Common Stock multiplied by the Current Market Price; such adjustment shall become effective as of the record date for the determination of shareholders entitled to receive such
distribution. The subdivision or combination of shares of Common Stock issuable upon exercise of this Warrant at any time outstanding into a greater or lesser number of shares of Common Stock shall not be deemed to be a reclassification of the
Common Stock of the Company of this clause (v). 
 (vi) Rounding of Calculations; Minimum Adjustment. All calculations under this
Section 3.1(a) and under Section 3.1(b) shall be made to the nearest cent. Any provision of this Section 3.1 to the contrary notwithstanding, no adjustment in the Exercise Price shall be made if the amount of such adjustment would be
less than one percent, but any such amount shall be carried forward and an adjustment with respect thereto shall 

  

 4 

 
be made at the time of and together with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward, shall
aggregate one percent or more. 
 (vii) Timing of Issuance of Additional Common Stock Upon Certain Adjustments. In any case in which
the provisions of this Section 3.1(a) shall require that an adjustment shall become effective immediately after a record date for an event, the Company may defer until the occurrence of such event issuing to the Registered Holder after such
record date and before the occurrence of such event the additional shares of Common Stock or other property issuable or deliverable upon exercise by reason of the adjustment required by such event over and above the shares of Common Stock or other
property issuable or deliverable upon such exercise before giving effect to such adjustment; provided, however, that the Company upon request shall deliver to such Registered Holder a due bill or other appropriate instrument evidencing
such Registered Holder’s right to receive such additional shares or other property, and such cash, upon the occurrence of the event requiring such adjustment. 
 (b) Statement Regarding Adjustments. Whenever the Exercise Price shall be adjusted as provided in Section 3.1(a), and upon each change in the number of shares of the Common Stock issuable upon exercise of
this Warrant, the Company shall forthwith file, at the office of any transfer agent for this Warrant and at the principal office of the Company, a statement showing in detail the facts requiring such adjustment and the Exercise Price and new number
of shares issuable that shall be in effect after such adjustment, and the Company shall also cause a copy of such statement to be given to the Registered Holder. Each such statement shall be signed by the Company’s chief financial or accounting
officer. Where appropriate, such copy may be given in advance and may be included as part of a notice required to be mailed under the provisions of Section 3.1(c). 
 (c) Notice to Holders. In the event the Company shall propose to take any action of the type described in clause (iii) or (iv) of Section 3.1(a), the Company shall give notice to the Registered
Holder, in the manner set forth in Section 6.6, which notice shall specify the record date, if any, with respect to any such action and the approximate date on which such action is to take place. Such notice shall also set forth such facts with
respect thereto as shall be reasonably necessary to indicate the effect of such action (to the extent such effect may be known at the date of such notice) on the Exercise Price and the number, kind or class of shares or other securities or property
which shall be deliverable upon exercise of this Warrant. In the case of any action which would require the fixing of a record date, such notice shall be given at least 10 days prior to the date so fixed, and in case of all other action, such notice
shall be given at least 15 days prior to the taking of such proposed action. Failure to give such notice, or any defect therein, shall not affect the legality or validity of any such action. 
 3.2 Costs. The Registered Holder shall pay all documentary, stamp, transfer or other transactional taxes attributable to the issuance or delivery
of the Warrant Shares upon exercise of this Warrant. Additionally, the Company shall not be required to pay any taxes which may be payable in respect of any transfer involved in the issuance or delivery of any certificate for such Warrant Shares.
The Registered Holder shall reimburse the Company for any such taxes assessed against the Company. 
 3.3 Reservations of Shares. The
Company shall reserve at all times so long as this Warrant remains outstanding, free from preemptive rights, out of its authorized but unissued shares of Common Stock, solely for the purpose of effecting the exercise of this Warrant, sufficient
shares of Common Stock to provide for the exercise hereof. 
 3.4 Valid Issuance. All shares of Common Stock which may be issued upon
exercise of this Warrant will upon issuance by the Company be duly and validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issuance thereof attributable to any act or omission by the Company,
and the Company shall take no action which will cause a contrary result (including without limitation, any action which would cause the Exercise Price to be less than the par value, if any, of the Common Stock). 
 ARTICLE IV 
 TERMS DEFINED

 As used in this Warrant, unless the context otherwise requires, the following terms have the respective meanings set forth below or in
the Section indicated: 
  

 5 

 Acquisition means the acquisition of the Company by another person or entity or group of
affiliated persons or entities by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger, or consolidation but excluding any merger effected exclusively for the purpose of changing the
domicile of the Company) that results in the transfer of more than 50% of the outstanding voting power of the Company. 
 Asset
Transfer means the sale, lease, or other transfer of all or substantially all of the assets of the Corporation 
 Board of
Directors means the Board of Directors of the Company. 
 Common Stock means the Company’s authorized Common Stock, no par
value per share. 
 Company means Bioject Medical Technologies Inc., an Oregon corporation, and any other corporation assuming or
required to assume the obligations undertaken in connection with this Warrant. 
 Current Market Price means the arithmetic average of
the closing price per share of the Common Stock on the Principal Market for the 20 consecutive Trading Days ending on and including the Trading Day immediately prior to the date in question. If the Current Market Price cannot be determined
under the foregoing method, the Current Market Price shall mean the fair value per share of Common Stock on such date as determined by the Board of Directors in good faith, irrespective of any accounting treatment. 
 Exchange Act means the Securities and Exchange Act of 1934, as amended. 
 Exercise Date is defined in Section 1.1. 
 Exercise Price is defined in the Preamble. 
 Majority Holders means at any time Registered
Holders of Warrant Shares which shares constitute a majority of the outstanding Warrant Shares. 
 Original Issue Date is defined in
Section 3.1(a)(i). 
 Outstanding means when used with reference to Common Stock at any date, all issued shares of Common Stock
(including, but without duplication, shares deemed issued pursuant to Article III) at such date. 
 Person means any individual,
corporation, partnership, trust, organization, association or other entity. 
 Principal Market means whichever of (a) the
national securities exchange, (b) the Nasdaq Capital Market, or (c) such other securities market on which the Common Stock is listed for trading which at such time constitutes the principal securities market for the Common Stock.

 Registered Holder is defined in the Preamble. 
 Securities Act means the Securities Act of 1933 and the rules and regulations promulgated thereunder, all as the same shall be in effect at the time. 
 Trading Day means a day on whichever of (a) the national securities exchange, (b) the Nasdaq Capital Market, or (c) such other
securities markets, in any case which at the time constitutes the Principal Market for the Common Stock, is open for general trading of securities. 
 Warrant means this Warrant and any successor or replacement Warrant delivered in accordance with Section 2.3 or 6.8. 
 Warrant Office is defined in Section 2.1. 
  

 6 

 Warrant Shares means the shares of Common Stock purchased or purchasable by the Registered Holder,
or the permitted assignees of such Registered Holder, upon exercise of this Warrant pursuant to Article I hereof. 
 ARTICLE V

 COVENANT OF THE COMPANY 
 The Company covenants and agrees that this Warrant shall be binding upon any corporation succeeding to the Company by merger, consolidation, or acquisition of all or substantially all of the Company’s assets. 
 ARTICLE VI 
 MISCELLANEOUS

 6.1 Entire Agreement. This Warrant and the Registration Rights Agreement contain the entire agreement between the Registered
Holder and the Company with respect to the Warrant Shares that it can purchase upon exercise hereof and the related transactions and supersedes all prior arrangements or understanding with respect thereto. 
 6.2 Governing Law. This Warrant shall be governed by and construed in accordance with the internal laws of the State of Oregon, without regard to
its conflict of law provisions. 
 6.3 Waiver and Amendment. Any term or provision of this Warrant may be waived at any time by the
party which is entitled to the benefits thereof, and any term or provision of this Warrant may be amended or supplemented at any time by written consent of the parties (it being agreed that an amendment to or waiver under any of the provisions of
Article III of this Warrant shall not be considered an amendment of the number of Warrant Shares or the Exercise Price). No waiver by any party of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or
not, shall be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way any rights arising because of any prior or subsequent such occurrence. 
 6.4 Illegality. In the event that any one or more of the provisions contained in this Warrant shall be determined to be invalid, illegal or
unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in any other respect and the remaining provisions of this Warrant shall not, at the election of the party for whom the benefit of the
provision exists, be in any way impaired. 
 6.5 Copy of Warrant. A copy of this Warrant shall be filed among the records of the
Company. 
 6.6 Notice. Any notice or other document required or permitted to be given or delivered to the Registered Holder shall be
delivered at, or sent by certified or registered mail to such Registered Holder at, the last address shown on the books of the Company maintained at the Warrant Office for the registration of this Warrant or at any more recent address of which the
Registered Holder shall have notified the Company in writing. Any notice or other document required or permitted to be given or delivered to the Company, other than such notice or documents required to be delivered to the Warrant Office, shall be
delivered at, or sent by certified or registered mail to, the office of the Company at 20245 S.W. 95th Avenue, Tualatin, Oregon 97062 or any other address within the continental United States of America as shall have been designated in writing by
the Company delivered to the Registered Holder. 
 6.7 Limitation of Liability; Not Stockholders. Subject to the provisions of Article
III, until the exercise of this Warrant, the Registered Holder shall not have or exercise any rights by virtue hereof as a stockholder of the Company, including, without limitation, the right to vote, to receive dividends and other distributions, or
to receive notice of, or attend meetings of stockholders or any other proceedings of the Company. Until the exercise of this Warrant, no provision hereof, and no mere enumeration herein of the rights or privileges of the Registered Holder, shall
give rise to any liability of such Registered Holder for the purchase price of any shares of Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company. 
  

 7 

 6.8 Exchange, Loss, Destruction, etc. of Warrant. Upon receipt of evidence satisfactory to the
Company (an affidavit of the Registered Holder shall be satisfactory evidence) of the loss, theft, mutilation or destruction of this Warrant, and, in the case of any such loss, theft or destruction, upon delivery of a bond of indemnity in such form
and amount as shall be reasonably satisfactory to the Company, or, in the event of such mutilation upon surrender and cancellation of this Warrant, the Company will make and deliver a new Warrant of like tenor, in lieu of such lost, stolen,
destroyed or mutilated Warrant; provided, however, that the original Registered Holder of this Warrant shall not be required to provide any such bond of indemnity and may in lieu thereof provide his agreement of indemnity. Any Warrant
issued under the provisions of this Section 6.8 in lieu of any Warrant alleged to be lost, destroyed or stolen, or in lieu of any mutilated Warrant, shall constitute an original contractual obligation on the part of the Company. This Warrant
shall be promptly canceled by the Company upon the surrender hereof in connection with any exchange or replacement. The Registered Holder of this Warrant shall pay all taxes (including securities transfer taxes) and all other expenses and charges
payable in connection with the preparation, execution and delivery of replacement Warrant(s) pursuant to this Section 6.8. 
 6.9
Headings. The Article and Section and other headings herein are for convenience only and are not a part of this Warrant and shall not affect the interpretation thereof. 
 6.10 Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to
the benefit of and be binding upon the successors of the Company and the successors and permitted assigns of Registered Holder. The provisions of this Warrant are intended to be for the benefit of all Registered Holders from time to time of this
Warrant and shall be enforceable by any such Registered Holder or holder of Warrant Shares. 
 IN WITNESS WHEREOF, the Company has caused
this Warrant to be signed in its name. 
 Dated: ________ 
  

			
	BIOJECT MEDICAL TECHNOLOGIES INC.
		
	By	 	 
	Name:	 	Christine M. Farrell
	Title:	 	Vice President of Finance

  

 8 

 Exhibit A 
 PURCHASE FORM 
  

			
	 To:   Bioject Medical Technologies Inc.
          20245 S.W. 95th Avenue
          Tualatin, Oregon 97062
	  	Dated:__________, 20___

 The undersigned, pursuant to the provisions set forth in the attached Warrant (No. ____), hereby
irrevocably elects to purchase ________ shares of the Common Stock covered by such Warrant. 
 The undersigned herewith makes payment of the
full exercise price for such shares at the price per share provided for in such Warrant, which is $_____ per share in lawful money of the United States. 
  

			
	[                                       
                                         
        ]
	
	
	
	
	
	 
		
	Name:	 	 
		
	Title:	 	 

  

 9 

 Exhibit B 
 ASSIGNMENT 
 For value received, ____________________________, hereby sells, assigns and transfers
unto _____________________ the within Warrant, together with all right, title and interest therein and does hereby irrevocably constitute and appoint attorney, to transfer said Warrant on the books of the Company, with full power of substitution.

  

			
	 

 Dated: ___________________, 20___ 
  

 10Option Agreement, dated June 19, 2008

 EXHIBIT 10.1 
 BASELINE OIL & GAS CORP. 
 STOCK OPTION AGREEMENT 
 This Stock Option Agreement (this “Agreement”) is effective as of June 19, 2008 (the “Option Grant Date”) by and
between Baseline Oil & Gas Corp., a Nevada corporation having its principal place of business at 411 North Sam Houston Parkway East, Suite 300, Houston, Texas 77060 (the “Company”), and Thomas R. Kaetzer, an individual
residing in the State of Texas (the “Optionee”). The Optionee and the Company hereby agree as follows: 
 1. Grant.
The Company hereby grants to the Optionee an option (the “Option”) to purchase up to an aggregate of 3,000,000 shares (the “Optioned Shares”) of the Company’s common stock, par value $0.001 per share (the
“Common Stock”), at an exercise price (the “Exercise Price”) of $0.40 per Optioned Share. 
 2.
Term. The Option granted hereby shall terminate no later than at the close of business on June 19, 2013 (the “Termination Date”). 
 3. Exercisability. The Option shall vest and may be exercised in whole or in part, from and after the Option Grant Date until the Termination Date. 
 4. Procedure for Exercise. 
 (a) Notice. The Optionee may exercise the Option at any time with respect to all or any part of the Optioned Shares by giving the Secretary of the Company written notice of intent to exercise. The notice of exercise shall specify the
number of Optioned Shares as to which the Option is to be exercised and the date of exercise thereof, which date shall be at least five days after the giving of such notice unless an earlier time shall have been mutually agreed upon. 
 (b) Payment of Exercise Price. Full payment (in U.S. Dollars) by the Optionee of the Exercise Price for the Optioned Shares
purchased shall be made on or before the exercise date specified in the notice of exercise in cash, or, with the prior written consent of the Board, in whole or in part through the surrender of previously acquired shares of Common Stock (valued at
their fair market value on the exercise date). If the Optionee fails to pay for any of the Optioned Shares specified in such notice or fails to accept delivery thereof, the Optionee’s right to purchase such Optioned Shares may be terminated by
the Company. The date specified in the Optionee’s notice as the date of exercise shall be deemed the date of exercise of the Option, provided that payment in full for the Optioned Shares to be purchased upon such exercise shall have been
received by such date. 
 (c) Cashless Exercise. In addition to the method of payment set forth above, provided that
the Common Stock is either registered on a national securities exchange or quoted on a national quotation system at the time of exercise, Optionee shall have the right to exercise this Option in full or in part by delivering written notice to the
Company, and Optionee shall receive the number of shares equal to the product of (x) the number of Optioned Shares as to which this Option is being exercised, multiplied by (y) a fraction, the numerator of which is the Market Price
(defined below) of the Common Stock minus the Exercise Price of the Optioned Shares and the denominator of which is the Market Price of the Common Stock. As used in this Agreement, the phrase “Market Price” for any given date shall
be deemed to be the last reported sale price on the trading day immediately preceding such date, or, in case no such reported sale takes place on such day, the average of the last reported sale prices for the last three (3) trading days
immediately preceding such date on which reported sales did take place, in either case as officially reported by the OTC Bulletin Board or the principal securities exchange on which the Common Stock is listed or admitted to trading if so listed and
admitted. 
  

 1 

 (d) Other Limitations on Exercise. The obligation of the Company to deliver shares
of Common Stock upon the exercise hereof shall be subject to the condition that if at any time the Company’s Board of Directors shall determine in its sole discretion that the listing, registration or qualification of the Option or the Optioned
Shares upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of, or in connection with, the grant of this Option or the issuance or
purchase of stock hereunder, then this Option may not be exercised in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of
Directors. 
 5. Adjustment of and Changes in Stock of Company. If the Company at any time after the Option Grant Date subdivides (by
any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately
reduced and the number of shares of Common Stock obtainable upon exercise of this Option will be proportionately increased. If the Company at any time after the Option Grant Date combines (by combination, reverse stock split or otherwise) one or
more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of shares issuable upon exercise of this
Option will be proportionately decreased. Any adjustment under this Section 5 shall become effective at the close of business on the date the subdivision or combination becomes effective. 
 6. Non-Transferability of Option. During the Optionee’s lifetime, this Option shall be exercisable only by the Optionee or any guardian or
legal representative of the Optionee, and the Option shall not be transferable except, in case of the death of the Optionee, by will or the laws of descent and distribution, nor shall the Option be subject to attachment, execution or other similar
process. In the event of (a) any attempt by the Optionee to alienate, assign, pledge, hypothecate or otherwise dispose of this Option, except as provided for herein, or (b) the levy of any attachment, execution or similar process upon the
rights or interest hereby conferred, the Company may terminate the Option by notice to the Optionee and it shall thereupon become null and void. 
 7. Restrictions on Underlying Stock. The shares of Common Stock issuable upon exercise of this Option may not be sold, pledged, hypothecated, transferred or assigned in the absence of an effective registration statement for the
securities under the applicable federal and state securities laws or an opinion of counsel satisfactory to the Company to the effect that such registration is not required thereunder. 
 8. “Piggy-Back” Registration Rights. If at any time commencing on the first anniversary of the date hereof and expiring five
(5) years hereafter, the Company proposes to register any of its securities under the Securities Act of 1933 (other than in connection with an initial public offering or in connection with a Form S-8 or any successor form as may be adopted by
the Securities and Exchange Commission), then the Company shall afford the Optionee the opportunity to include for sale in such registration statement, shares of Common Stock acquired by the Optionee upon the exercise of this Option;
provided, however, that if the Company’s underwriter shall advise the Company in writing that in its opinion the number of shares to be included in such registration is too large, then the Company will include only such number of
Option Shares as such underwriter shall so advise. 
  

 2 

 9. Nonqualified Option. The Option granted hereby shall be treated as a nonqualified stock option
and not as an incentive stock option under the Internal Revenue Code. 
 10. No Rights as Stockholder. Neither the Optionee nor any
personal representatives shall be, or shall have any of the rights and privileges of, a stockholder of the Company with respect to any shares of Common Stock purchasable or issuable upon the exercise of this Option, in whole or in part, prior to the
date of exercise of this Option in accordance with the provisions hereof, and then only to the extent of the shares of Common Stock so purchased or issued. 
 11. Successors and Assigns. This Option shall not be assignable by the Optionee without the prior consent of the Company, which shall not be unreasonably withheld. This Option shall be binding upon the
successors and assigns of the Company, and shall be expressly assumed by any successor to the Company pursuant to a merger in which the Company is not the surviving entity. 
 12. Miscellaneous. This Option and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination is sought. This certificate is deemed to have been delivered in the State of Texas and shall be construed and enforced in accordance with and governed by the laws of
such State. The headings in this Stock Option Agreement are for purposes of reference only, and shall not limit or otherwise affect any of the terms hereof. 
 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by a duly authorized representative and the Optionee has hereunto set his hand as of the Option Grant Date. 
  

					
	 	 	BASELINE OIL & GAS CORP.
	 By:
	 	 /s/ Patrick H. McGarey

		 	Name:	 	Patrick H. McGarey
		 	Title:	 	Chief Financial Officer
		
		 	 /s/ Thomas R. Kaetzer

		 	Thomas R. Kaetzer

  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}]]